In The News

New malaria tool shows which kids at greatest risk

Karl Seydel, MSU assistant professor of osteopathic medical specialties, cares for a child with malaria in Blantyre, Malawi. Seydel and colleagues discovered a test that can help clinicians make crucial decisions about which malaria patients face the greatest risk for developing a life-threatening form of the disease.

Message to Doctors: "Take the Chance"

"Physicians apparently are afraid to give thrombolytic drugs to pulmonary embolism patients if they are elderly or have associated illnesses, and for good reason," says Paul Stein, a professor at Michigan State. "Bleeding can be severe with such drugs, but the fact is, a lot more patients die if they don't get the drug than if they do." 

Laryssa Kaufman, M.D. 2011-2012 Curricular Service-Learning and Civic Engagement Award, College of Osteopathic Medicine.  Awarded for her work in developing and implementing a new curricular model for the college.  The annual award recognizes innovative and/or sustained effort in the area of academic, curricular or co-curricular service-learning/civic engagement that is specifically linked with the mission and efforts of each college at Michigan State University.

Dr. Gulick: New HIV/AIDS registry to help answer key questions:  A new community-based HIV/AIDS registry, one of the first in the nation to include patients from rural areas, will provide a unique opportunity to find answers to myriad medical questions, from the impact of drugs such as marijuana on the virus to why some patients naturally ward off the disease.

Procedure Doesn't Lower Pulmonary Embolism Mortality Vena cava filters do not lower pulmonary embolism death risk, Paul Stein, MD, a lead researcher, professor in Osteopathic Medical Specialties at Michigan State University COM and director of research at St. Mary Mercy Hospital, noted that hospitals have increased their use of vena cava filters for pulmonary embolism patients in recent years.  web link